## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `semaglutide`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/semaglutide/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/semaglutide/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/semaglutide/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/semaglutide/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/semaglutide/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/semaglutide/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `semaglutide` v3 · content_hash `dcd6b7bdb3704e6e…` · thread_head genesis · 2 DIVs
- **thesis:** FLAGGED — this article's thesis does not reduce to one falsifiable root claim — audit finding, not fudged
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/semaglutide/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/semaglutide/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `semaglutide`
- **title:** semaglutide
- **url:** https://miscsubjects.com/a/semaglutide
- **register:** standard
- **updated:** 2026-07-17T02:41:42.872Z

## Body

## Overview
Evidence is being populated by Grok web search.

## Claims (0)


## Voxel graph (0 atoms · 0 edges)
- full graph: https://miscsubjects.com/api/articles/semaglutide/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (9)
- chain valid: yes · head: `e143dd5e102d4967`

### s1 · pubmed · ok
- title: Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
- url: https://pubmed.ncbi.nlm.nih.gov/40934115/
- summary: 71-week RCT: -13.6% weight loss with 25 mg oral sema vs -2.2% placebo; more GI AEs.
- quote: Oral semaglutide at a dose of 25 mg once daily resulted in a greater mean reduction in body weight than placebo in participants with overweight or obesity. (Funded by Novo Nordisk; OASIS 4 ClinicalTrials.gov number, NCT05564117.).
- hash: `bb8f7bdc39d23ad4`

### s2 · pubmed · ok
- title: Once-weekly semaglutide 7·2 mg in adults with obesity
- url: https://pubmed.ncbi.nlm.nih.gov/40961952/
- summary: Phase 3 trial of higher-dose semaglutide 7.2 mg for obesity.
- quote: Semaglutide 7·2 mg was superior to placebo and 2·4 mg for bodyweight reduction in adults with obesity, while retaining a favourable risk-benefit profile.
- hash: `a26d95c594e153fa`

### s3 · pubmed · ok
- title: Semaglutide in Adults with Type 1 Diabetes and Obesity
- url: https://pubmed.ncbi.nlm.nih.gov/40550013/
- summary: RCT evaluating semaglutide in T1D + obesity.
- quote: Once-weekly semaglutide is approved for the management of type 2 diabetes and obesity. The efficacy and safety of semaglutide in adults with type 1 diabetes and obesity are unknown.
- hash: `b8aa6e33c7d6a958`

### s4 · review · ok
- title: The expanding role of semaglutide: beyond glycemic control
- url: https://pubmed.ncbi.nlm.nih.gov/40620322/
- summary: 2025 review on semaglutide's expanding indications (NAFLD, HF, PCOS, etc.).
- quote: This review outlines semaglutide's diverse mechanisms of action, including its roles in glucose homeostasis, weight reduction, and cardiovascular protection.
- hash: `5ba89ac1dc2887ca`

### s5 · clinical_trial · ok
- title: Phase III Clinical Study on the Efficacy and Safety of Semaglutide
- url: https://clinicaltrials.gov/study/NCT07046273
- summary: New Phase III trial registration for semaglutide (Jul 2025).
- quote: A way for patients with serious diseases or conditions who cannot participate in a clinical trial to gain access to a medical product that has not been approved ...
- hash: `43aabd42096e8232`

### s6 · pubmed · ok
- title: Semaglutide in cardiovascular and kidney disease
- url: https://pubmed.ncbi.nlm.nih.gov/40458885/
- summary: Discusses semaglutide benefits in CV and kidney outcomes.
- quote: Semaglutide enhances glycemic control , reduces major adverse CV events (MACE), and slows chronic kidney disease (CKD) progression.
- hash: `ad426f57cb10fd75`

### s7 · clinical_trial · ok
- title: Weight Loss in Adults Using Semaglutide (Real-world Study)
- url: https://clinicaltrials.gov/study/NCT07627074
- summary: Real-world study on semaglutide weight loss, published Jun 2026.
- quote: The purpose of the study is to assess the weight loss in participants treated with commercially available semaglutide according to routine clinical practice at ...
- hash: `cd0c8309e785256b`

### s8 · pubmed · ok
- title: Weight Loss Effects of Once-Weekly Semaglutide 2.4 mg in ...
- url: https://pubmed.ncbi.nlm.nih.gov/40732345/
- summary: Study on weight loss efficacy of semaglutide 2.4 mg.
- quote: Conclusions: The observed difference in weight loss efficacy between the groups was clinically meaningful. While once-weekly semaglutide at 2.4 mg elicited ...
- hash: `d0fbb127adadc67f`

### s9 · pubmed · ok
- title: Semaglutide and Hospitalizations in Patients With Obesity ...
- url: https://pubmed.ncbi.nlm.nih.gov/41433034/
- summary: Exploratory analysis from SELECT trial on hospitalizations.
- quote: Treatment with once-weekly semaglutide was associated with significant reductions in hospital admissions and overall time spent in hospital, ...
- hash: `e143dd5e102d4967`

## Provenance (4 model passes)
- chain valid: yes · head: `ae238610ebda3507`

- populate-init · grok-4.3 · 2026-06-29T17:00 · hash `209726646dd5`
- sources · grok-4.3 · 2026-06-29T17:01 · hash `0315feba5460`
- sources · grok-4.3 · 2026-06-29T17:01 · hash `3ca2ad3327c7`
- voxel_divide · owner · 2026-07-17T02:41 · hash `ae238610ebda`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/semaglutide/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/semaglutide/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"semaglutide","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest semaglutide|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim semaglutide|tier|assertion`
- **iMessage ask:** `semaglutide|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `semaglutide`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/semaglutide/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/semaglutide/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*